Common use of Introduction and Statement of Policy Clause in Contracts

Introduction and Statement of Policy. The National Institute on Aging (NIA) has established the NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) as a resource to serve as a repository for many types of data generated by NIA supported grants and cooperative agreements and/or NIA funded biological samples. NIAGADS operates under the NIH Genomics Data Sharing Policy (GDS) and the NIA Genetics of Alzheimer’s Disease Data Sharing Policy. Because the human genomic and phenotypic data contained in NIAGADS is, in some instances, potentially sensitive information, e.g., data related to the presence or risk of developing Alzheimer’s Disease and related neurodegenerative disorders, and information regarding family relationships or ancestry, data must be shared in a manner consistent with the research participants’ informed consent, and the confidentiality of the data and the privacy of participants must be protected. Access to human genomic data will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. It is the intent of NIH and the National Institute on Aging (NIA) that approved users of datasets obtained through this NIAGADS Data Access Request (DAR) recognize any restrictions on data use established by the submitting institution through the Institutional Certification and stated on the NIAGADS website ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇/. Definitions of terminology in this document are found in section 14. The parties to this agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (an “Approved User”), the PI’s home institution as represented by the Institutional Signing Official (the “Requester”), and NIAGADS. The effective date of this agreement shall be the Project Approval Date, as specified on the NIAGADS approval notification.

Introduction and Statement of Policy. The National Institute on Aging Institutes of Health (NIANIH) has established the NIA Genetics NIH-designated data repositories (e.g., database of Alzheimer’s Disease Data Storage Site Genotypes and Phenotypes (NIAGADSdbGaP), Sequence Read Archive (SRA), NIH Established Trusted Partnerships) as a resource for securely storing and sharing controlled-access human data submitted to serve as a repository for many types of data generated by NIA supported grants and cooperative agreements and/or NIA funded biological samples. NIAGADS operates NIH under the NIH Genomics Genomic Data Sharing Policy (GDS) and the NIA Genetics of Alzheimer’s Disease Data Sharing Policy. Because the volume of human genomic and phenotypic data contained in NIAGADS isthese repositories is substantial and, in some instances, potentially sensitive information, (e.g., data related to the presence or risk of developing Alzheimer’s Disease and related neurodegenerative disorders, particular diseases or conditions and information regarding family relationships or ancestry), data must be shared in a manner consistent with the research participants’ informed consent, and the confidentiality of the data and the privacy of participants must be protected. Access to human genomic data will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. It is the intent of NIH and the National Institute on Aging (NIA) NCI that approved users of controlled-access datasets obtained through this NIAGADS Data Access Request (DAR) DAR recognize any restrictions on data use established by the submitting institution through the Institutional Certification and stated on the NIAGADS website ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇/. dbGaP study page. Definitions of terminology used in this document are found in section 14the Appendix. The parties to this agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (an “Approved User”), the PI’s home institution as represented by the Institutional Signing Official designated through the eRA Commons system (the “Requester”), and NIAGADSthe relevant NIH Institute or Center (IC). The effective date of this agreement shall be the Project Approval Date, as specified on the NIAGADS Data Access Committee (DAC) approval notification.

Introduction and Statement of Policy. The National Institute on Aging (NIA) has established the NIA Genetics of Alzheimer’s Disease Data Storage Site (NIAGADS) as a resource to serve as a repository for many types of data generated by NIA supported grants and cooperative agreements and/or NIA funded biological samples. NIAGADS operates under the NIH Genomics Data Sharing Policy (GDS) and the NIA Genetics Genomics of Alzheimer’s Disease Data Sharing PolicyPolicy . Because the human genomic and phenotypic data contained in NIAGADS is, in some instances, potentially sensitive information, e.g., data related to the presence or risk of developing Alzheimer’s Disease and related neurodegenerative disorders, and information regarding family relationships or ancestry, data must be shared in a manner consistent with the research participants’ informed consent, and the confidentiality of the data and the privacy of participants must be protected. Access to human genomic data will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. It is the intent of NIH and the National Institute on Aging (NIA) that approved users of datasets obtained through this NIAGADS Data Access Request (DAR) recognize any restrictions on data use established by the submitting institution through the Institutional Certification and stated on the NIAGADS website ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇/. Definitions of terminology used in this document are found in section 14the Appendix. The parties to this agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (an “Approved User”), the PI’s home institution as represented by the Institutional Signing Official (the “Requester”), and NIAGADS. The effective date of this agreement shall be the Project Approval Date, as specified on the NIAGADS approval notification.

Introduction and Statement of Policy. The National Institute on Aging Institutes of Health (NIANIH) has established the NIA Genetics NIH-designated data repositories (e.g., database of Alzheimer’s Disease Data Storage Site Genotypes and Phenotypes (NIAGADSdbGaP), Sequence Read Archive (SRA), NIH Established Trusted Partnerships) as a resource for securely storing and sharing controlled-access human data submitted to serve as a repository for many types of data generated by NIA supported grants and cooperative agreements and/or NIA funded biological samples. NIAGADS operates NIH under the NIH Genomics Genomic Data Sharing Policy (GDS) and the NIA Genetics of Alzheimer’s Disease Data Sharing Policy. Because the volume of human genomic and phenotypic data contained in NIAGADS isthese repositories is substantial and, in some instances, potentially sensitive information, (e.g., data related to the presence or risk of developing Alzheimer’s Disease and related neurodegenerative disorders, particular diseases or conditions and information regarding family relationships or ancestry), data must be shared in a manner consistent with the research participants’ informed consent, and the confidentiality of the data and the privacy of participants must be protected. Access to human genomic data will be provided to research investigators who, along with their institutions, have certified their agreement with the expectations and terms of access detailed below. It is the intent of NIH and the National Institute on Aging (NIA) NLM that approved users of controlled-access datasets obtained through this NIAGADS Data Access Request (DAR) DAR recognize any restrictions on data use established by the submitting institution through the Institutional Certification and stated on the NIAGADS website ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇/. dbGaP study page. Definitions of terminology used in this document are found in section 14the Appendix. The parties to this agreement include: the Principal Investigator (PI) requesting access to the genomic study dataset (an “Approved User”), the PI’s home institution as represented by the Institutional Signing Official designated through the eRA Commons system (the “Requester”), and NIAGADSthe relevant NIH Institute or Center (IC). The effective date of this agreement shall be the Project Approval Date, as specified on the NIAGADS Data Access Committee (DAC) approval notification.